Short Interest in F/m Emerald Life Sciences Innovation ETF (NASDAQ:LFSC) Drops By 50.9%

F/m Emerald Life Sciences Innovation ETF (NASDAQ:LFSC) was the recipient of a large decline in short interest during the month of April. As of April 30th, there was short interest totaling 2,968 shares, a decline of 50.9% from the April 15th total of 6,046 shares. Based on an average trading volume of 3,055 shares, the days-to-cover ratio is presently 1.0 days. Currently, 0.1% of the company’s shares are short sold.

F/m Emerald Life Sciences Innovation ETF Price Performance

LFSC opened at $37.11 on Monday. F/m Emerald Life Sciences Innovation ETF has a fifty-two week low of $22.53 and a fifty-two week high of $40.10. The company’s 50 day moving average price is $36.06 and its two-hundred day moving average price is $36.09.

Institutional Investors Weigh In On F/m Emerald Life Sciences Innovation ETF

A hedge fund recently raised its stake in F/m Emerald Life Sciences Innovation ETF stock. Hunter Associates Investment Management LLC boosted its holdings in shares of F/m Emerald Life Sciences Innovation ETF (NASDAQ:LFSC) by 13.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 45,908 shares of the company’s stock after acquiring an additional 5,312 shares during the quarter. Hunter Associates Investment Management LLC owned 1.81% of F/m Emerald Life Sciences Innovation ETF worth $1,684,000 at the end of the most recent quarter.

About F/m Emerald Life Sciences Innovation ETF

The F/M Emerald Life Sciences Innovation ETF (LFSC) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed ETF that targets US health care and biotechnology companies identified to have promising life sciences opportunities. LFSC was launched on Oct 31, 2024 and is issued by F/m Investments.